NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 15 10:53AM ET
15.54
Dollar change
-0.24
Percentage change
-1.52
%
Index- P/E119.54 EPS (ttm)0.13 Insider Own- Shs Outstand53.86M Perf Week-1.27%
Market Cap837.02M Forward P/E- EPS next Y- Insider Trans- Shs Float53.86M Perf Month-2.08%
Enterprise Value- PEG- EPS next Q- Inst Own22.10% Short Float0.09% Perf Quarter4.44%
Income- P/S82.09 EPS this Y- Inst Trans- Short Ratio0.24 Perf Half Y-6.39%
Sales10.20M P/B0.88 EPS next Y- ROA- Short Interest0.05M Perf YTD-3.18%
Book/sh17.66 P/C- EPS next 5Y- ROE- 52W High19.79 -21.48% Perf Year-14.29%
Cash/sh- P/FCF- EPS past 3/5Y- - ROIC- 52W Low13.77 12.85% Perf 3Y-20.88%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility1.50% 1.57% Perf 5Y-28.10%
Dividend TTM2.32 (14.93%) EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.27 Perf 10Y-55.57%
Dividend Ex-DateMay 22, 2025 Quick Ratio- Sales Y/Y TTM- Profit Margin- RSI (14)46.99 Recom-
Dividend Gr. 3/5Y3.78% 5.85% Current Ratio- EPS Q/Q- SMA20-0.42% Beta0.71 Target Price-
Payout55.68% Debt/Eq- Sales Q/Q-10.80% SMA50-0.36% Rel Volume0.95 Prev Close15.78
Employees- LT Debt/Eq- Earnings- SMA200-7.47% Avg Volume207.23K Price15.54
IPOApr 23, 1987 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume49,869 Change-1.52%
Jun-30-25 04:17PM
May-28-25 06:13PM
May-09-25 04:17PM
Apr-14-25 03:01PM
Mar-31-25 04:27PM
02:50AM Loading…
Mar-30-25 02:50AM
Feb-11-25 04:37PM
Jan-10-25 04:17PM
Nov-11-24 04:17PM
Oct-22-24 09:07PM
Sep-30-24 04:17PM
Aug-09-24 04:17PM
Jun-28-24 04:17PM
Jun-26-24 06:08PM
May-09-24 05:45PM
04:17PM Loading…
Mar-28-24 04:17PM
Mar-21-24 07:59AM
Feb-09-24 05:23PM
Jan-10-24 04:17PM
Oct-27-23 05:20PM
04:57PM
04:57PM
Oct-13-23 06:26PM
Oct-05-23 02:05PM
Sep-29-23 10:35AM
Sep-25-23 09:01PM
Sep-21-23 05:01AM
Sep-13-23 08:51AM
Aug-30-23 02:39PM
Aug-15-23 09:55AM
03:10PM Loading…
Aug-14-23 03:10PM
Jun-30-23 10:35AM
Jun-20-23 06:15PM
05:48PM
May-15-23 10:36AM
Mar-31-23 09:55AM
09:55AM
09:55AM
09:55AM
Mar-16-23 02:40PM
Feb-15-23 10:33AM
Dec-30-22 09:55AM
09:55AM
09:55AM
09:55AM
Nov-15-22 09:56AM
Sep-30-22 10:22AM
Aug-16-22 10:10AM
Jul-29-22 10:35AM
10:35AM
Jun-30-22 11:10AM
11:10AM
11:10AM
11:10AM
May-17-22 11:44AM
Mar-31-22 10:52AM
Mar-22-22 10:23AM
Feb-28-22 10:54AM
10:54AM
Feb-15-22 01:15PM
Jan-31-22 11:08AM
11:07AM
Jan-19-22 01:38PM
Dec-31-21 10:21AM
10:20AM
10:20AM
10:20AM
Nov-30-21 02:24PM
02:24PM
Nov-12-21 12:35PM
Oct-29-21 11:17AM
11:17AM
Sep-30-21 10:34AM
10:34AM
10:34AM
10:34AM
Aug-31-21 11:05AM
11:05AM
Aug-17-21 11:10AM
Jul-30-21 11:58AM
11:58AM
Jun-30-21 10:17AM
10:17AM
10:16AM
10:16AM
May-28-21 10:25AM
10:25AM
May-18-21 10:25AM
Apr-30-21 02:10PM
02:10PM
Mar-31-21 10:52AM
10:51AM
10:46AM
10:43AM
Mar-25-21 04:10PM
Feb-26-21 12:10PM
12:10PM
Feb-16-21 10:35AM
Jan-29-21 11:35AM
11:35AM
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DiMartino RoseDirectorJul 16 '24Buy18.881,00018,8801,000Jul 18 02:54 PM